Today’s biotech and pharmaceutical production facilities must drive faster times to market and greater profitability by boosting production yields and accelerating commercialization.
A startup medical diagnostics company specializing in tests that identify and characterize tumor cells in blood samples chose to implement a cloud-hosted Core LIMS in their laboratories to support anticipated future growth. The diagnostics company decided that they did not want to rely on the vendor’s services, and therefore asked Core Informatics to recommend a quality informatics consultant to support the implementation. Core Informatics referred the diagnostics company to Astrix Technology Group for development and implementation services, as Astrix’s core technical team has been trained by Core Informatics experts, and Astrix has worked alongside Core Informatics on many implementation projects.
The reality is that paper is more of a habit than a requirement. AstraZeneca discovered this when they aimed to introduce ELNs to improve the efficiency of their validated workflows for GMP API manufacture.
“Digital transformation” is a common buzzword across industries today, but is it more than just jargon? Faced by shifting consumer demand, rapidly evolving technology and increasing competition, organizations — to a large extent from science-based industries — are realizing that business as usual (or only incremental change to traditional approaches) does not address today’s challenges in a sustainable, long-term way.
According to over 200 life sciences companies surveyed, the number one challenge in speeding products from R&D to patients is quality management, which may surprise many executives that have spent the past decade focused on other issues like validation, regulatory, or supply chain.
A major research-based biopharmaceutical company was working with a commercial LIMS vendor to implement a LIMS for the Biometrics department. Both the biopharmaceutical company and the LIMS vendor had project teams which interfaced closely to move the project forward.
The trend towards virtual pharma is accelerating and as it does, the life sciences industry is undergoing a profound structural change. The areas of development and commercialization which were once conducted within the confines of one company have now become a collaboration within an ecosystem of entities, both public and private.
Laboratories can now rely on Thermo Fisher Scientific’s expanded line of cold-storage products to help them meet their goals for both productivity and sustainability. The company recently earned the U.S. Environmental Protection Agency’s (EPA’s) ENERGY STAR certification for its Thermo Scientific TSX Series ultra-low temperature freezers, which is designed to reduce energy consumption while ensuring sample protection.